GPB Capital Funds Lawsuit Seeks Class Action Status for Investors

Brokerage firms who sold GPB funds, which it now appears were operated as a Ponzi scheme, face a class action lawsuit over improper conduct, seeking damages for investors who have been left with substantial losses.

A complaint (PDF) filed last month by Kinnie Ma, of California, names as defendants GPB Capital Holdings and other GPB funds, as well as a long list of brokerages and firms who sold the funds to investors. It also names GPB CEO David Gentile, co-founder Jeffrey Schneider and others involved in the operation of the funds.

GPB Capital Holdings focused on auto dealerships and waste management companies, but plaintiffs and critics say that it was using money from its investors to make the auto dealerships appear to be performing better than they actually were, and then using money from new investors to pay off prior investors, claiming the funds were a profit.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Troubles first began to appear when GPB Capital Holdings missed a filing with the Securities Exchange Commission (SEC) in April 2018. It stopped paying distributions in December 2018, and in March of this year the FBI raided its offices.

Amid allegations of a so-called “Ponzi” scheme, and claims that it had been falsifying its records, the value of the two biggest GPB Capital investment funds have sharply declined, with some investors claiming they have lost between 25% and 75%. GPB focused on private placement investments, which are generally considered suitable only for accredited investors.

A number of investors are now pursuing GPB Capital lawsuits, indicating that they were not informed of the actual risks associated with the private placement. However, some are going further and saying the entire company was a scam.

In the complaint filed by Ma, it is alleged that one part of that scam was Ascendant Capital, LLC, which was launched by Schneider for the specific purpose of selling GPB funds. As a co-founder, he helped both operate the funds and then acted as a broker in selling the funds. However, neither the funds nor Ascendant Capital informed investors of the relationship.

“These material conflicts of interest were never fully disclosed throughout the GPB Ponzi scheme,” the lawsuit states. “Thus, investors did not know when they invested that Schneider and Ascendant, the lead broker for GPB securities, were conflicted by Schneider’s financial interest in GPB or that Gentile and GPB were conflicted by their interest in the broker selling GPB limited partnership interests.”

The lawsuit accused the business model of being destined to fail, like all Ponzi schemes, designed to leave investors holding the bag.

Investigations are underway by the SEC, the FBI, the Financial Industry Regulatory Authority (FINRA), New Jersey, and Massachusetts. Of the 80 brokerage firms authorized to sell GPB investments, 60 are also under investigation by Massachusetts officials.

Brokers are responsible for conducting due diligence and making sure investments being sold to their clients are legitimate.

In Ponzi schemes, a firm or individual offers high rates of investment returns, claiming there is little risk for investors. It pays early investors from investments by new investors, claiming the funds came from business growth.

This makes it look extremely profitable at first, but eventually new investors stop signing on or there are too many investors to spread the money out to make the investments appear profitable.

Things also often break down after concerns become public, and then it is revealed that there are no liquid assets, and investors generally suffer major losses unless they got out early. It is considered the financial market’s version of a pyramid scheme.

Reports suggest that GPB has raised about $1.8 billion from investors since 2013.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted yesterday)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 2 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 3 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.